Price Cost Schedule.xlsx

This is a Price Cost Schedule for a firm-fixed-price contract to supply unit dose radiopharmaceuticals for nuclear medicine procedures at the Department of Veterans Affairs. The contract covers a base period from March 1, 2026 through February 28, 2027, with four optional one-year renewal periods extending through February 28, 2031. The schedule itemizes 43 line items across five contract periods, including various Tc99m radiopharmaceutical products (DTPA, ECD, HMPAO, MAA, MAG3, MDP, Mebrofenin, PYP, Sestamibi, NaTcO4, Sulfur Colloid, and Tetrofosmin), other diagnostic isotopes (Gallium-67 Citrate, I-123 Capsules, I-131 Capsules, In-111 DTPA, Tl-201 Chloride, and Xe-133 gas), specialty items (labeled leukocytes and kits), and ancillary services.

Estimated quantities remain constant across all five contract periods for each line item, ranging from single units to 3,050 units annually for specific products. The schedule also includes service items such as standard weekday deliveries (5 days per period), emergency after-hours deliveries (15 events annually), pharmacist emergency call-back services (15 events annually), weekend white blood cell labeling charges, and Ioflupane I-123 services (25 events annually). Bidders are required to complete this schedule with unit prices and extended amounts for the base period and each option year to establish the total contract cost across all five years of performance.